Metagenomi (MGX) Research & Development (2023 - 2025)
Historic Research & Development for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $25.3 million.
- Metagenomi's Research & Development fell 370.58% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.1 million, marking a year-over-year decrease of 1324.73%. This contributed to the annual value of $109.2 million for FY2024, which is 1565.2% up from last year.
- According to the latest figures from Q3 2025, Metagenomi's Research & Development is $25.3 million, which was down 370.58% from $22.5 million recorded in Q2 2025.
- Metagenomi's 5-year Research & Development high stood at $31.4 million for Q1 2024, and its period low was $20.1 million during Q1 2023.
- For the 3-year period, Metagenomi's Research & Development averaged around $25.1 million, with its median value being $25.1 million (2025).
- As far as peak fluctuations go, Metagenomi's Research & Development soared by 5617.98% in 2024, and later tumbled by 2052.61% in 2025.
- Metagenomi's Research & Development (Quarter) stood at $24.8 million in 2023, then dropped by 6.43% to $23.2 million in 2024, then increased by 9.15% to $25.3 million in 2025.
- Its last three reported values are $25.3 million in Q3 2025, $22.5 million for Q2 2025, and $25.1 million during Q1 2025.